TFA Therapeutics, Inc. (RAJAF)
OTC Markets OTCQB · USD · Consumer Defensive · Packaged Foods
$9.18 (+0.00%) as of
Key statistics
- Market cap
- 1.02B
- EPS (TTM)
- 0.00
- 52-week range
- 3.01 – 9.18
- Beta
- -54.15
- Revenue (TTM)
- 1.25M
- Profit margin
- -12.43%
- Volume
- 154.00
About TFA Therapeutics, Inc.
TFA Therapeutics, Inc. develops TFA-01 novel nonsteroidal anti-inflammatory drugs for pet medical care. It offers drugs in the areas of canine osteoarthritis, dermatitis, and feline stomatitis. The company serves customers in Taiwan, Japan, Greater China, and United States. TFA Therapeutics, Inc. was formerly known as Cordyceps Sunshine Biotech Holdings Co., Ltd. and changed its name to TFA Therapeutics, Inc. in July 2026. The company was incorporated in 2020 and is based in Taipei, Taiwan.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Taipei, Taiwan
- Employees
- 15
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.